_version_ 1866914782819385344
author Korablyov, Maksym
Liu, Cheng-Hao
Jain, Moksh
van der Sloot, Almer M.
Jolicoeur, Eric
Ruediger, Edward
Nica, Andrei Cristian
Bengio, Emmanuel
Lapchevskyi, Kostiantyn
St-Cyr, Daniel
Schuetz, Doris Alexandra
Butoi, Victor Ion
Rector-Brooks, Jarrid
Blackburn, Simon
Feng, Leo
Nekoei, Hadi
Gottipati, SaiKrishna
Vijayan, Priyesh
Gupta, Prateek
Rampášek, Ladislav
Avancha, Sasikanth
Bacon, Pierre-Luc
Hamilton, William L.
Paige, Brooks
Misra, Sanchit
Jastrzebski, Stanislaw Kamil
Kaul, Bharat
Precup, Doina
Hernández-Lobato, José Miguel
Segler, Marwin
Bronstein, Michael
Marinier, Anne
Tyers, Mike
Bengio, Yoshua
author_facet Korablyov, Maksym
Liu, Cheng-Hao
Jain, Moksh
van der Sloot, Almer M.
Jolicoeur, Eric
Ruediger, Edward
Nica, Andrei Cristian
Bengio, Emmanuel
Lapchevskyi, Kostiantyn
St-Cyr, Daniel
Schuetz, Doris Alexandra
Butoi, Victor Ion
Rector-Brooks, Jarrid
Blackburn, Simon
Feng, Leo
Nekoei, Hadi
Gottipati, SaiKrishna
Vijayan, Priyesh
Gupta, Prateek
Rampášek, Ladislav
Avancha, Sasikanth
Bacon, Pierre-Luc
Hamilton, William L.
Paige, Brooks
Misra, Sanchit
Jastrzebski, Stanislaw Kamil
Kaul, Bharat
Precup, Doina
Hernández-Lobato, José Miguel
Segler, Marwin
Bronstein, Michael
Marinier, Anne
Tyers, Mike
Bengio, Yoshua
contents Despite substantial progress in machine learning for scientific discovery in recent years, truly de novo design of small molecules which exhibit a property of interest remains a significant challenge. We introduce LambdaZero, a generative active learning approach to search for synthesizable molecules. Powered by deep reinforcement learning, LambdaZero learns to search over the vast space of molecules to discover candidates with a desired property. We apply LambdaZero with molecular docking to design novel small molecules that inhibit the enzyme soluble Epoxide Hydrolase 2 (sEH), while enforcing constraints on synthesizability and drug-likeliness. LambdaZero provides an exponential speedup in terms of the number of calls to the expensive molecular docking oracle, and LambdaZero de novo designed molecules reach docking scores that would otherwise require the virtual screening of a hundred billion molecules. Importantly, LambdaZero discovers novel scaffolds of synthesizable, drug-like inhibitors for sEH. In in vitro experimental validation, a series of ligands from a generated quinazoline-based scaffold were synthesized, and the lead inhibitor N-(4,6-di(pyrrolidin-1-yl)quinazolin-2-yl)-N-methylbenzamide (UM0152893) displayed sub-micromolar enzyme inhibition of sEH.
format Preprint
id arxiv_https___arxiv_org_abs_2405_01616
institution arXiv
publishDate 2024
record_format arxiv
spellingShingle Generative Active Learning for the Search of Small-molecule Protein Binders
Korablyov, Maksym
Liu, Cheng-Hao
Jain, Moksh
van der Sloot, Almer M.
Jolicoeur, Eric
Ruediger, Edward
Nica, Andrei Cristian
Bengio, Emmanuel
Lapchevskyi, Kostiantyn
St-Cyr, Daniel
Schuetz, Doris Alexandra
Butoi, Victor Ion
Rector-Brooks, Jarrid
Blackburn, Simon
Feng, Leo
Nekoei, Hadi
Gottipati, SaiKrishna
Vijayan, Priyesh
Gupta, Prateek
Rampášek, Ladislav
Avancha, Sasikanth
Bacon, Pierre-Luc
Hamilton, William L.
Paige, Brooks
Misra, Sanchit
Jastrzebski, Stanislaw Kamil
Kaul, Bharat
Precup, Doina
Hernández-Lobato, José Miguel
Segler, Marwin
Bronstein, Michael
Marinier, Anne
Tyers, Mike
Bengio, Yoshua
Biomolecules
Artificial Intelligence
Machine Learning
Despite substantial progress in machine learning for scientific discovery in recent years, truly de novo design of small molecules which exhibit a property of interest remains a significant challenge. We introduce LambdaZero, a generative active learning approach to search for synthesizable molecules. Powered by deep reinforcement learning, LambdaZero learns to search over the vast space of molecules to discover candidates with a desired property. We apply LambdaZero with molecular docking to design novel small molecules that inhibit the enzyme soluble Epoxide Hydrolase 2 (sEH), while enforcing constraints on synthesizability and drug-likeliness. LambdaZero provides an exponential speedup in terms of the number of calls to the expensive molecular docking oracle, and LambdaZero de novo designed molecules reach docking scores that would otherwise require the virtual screening of a hundred billion molecules. Importantly, LambdaZero discovers novel scaffolds of synthesizable, drug-like inhibitors for sEH. In in vitro experimental validation, a series of ligands from a generated quinazoline-based scaffold were synthesized, and the lead inhibitor N-(4,6-di(pyrrolidin-1-yl)quinazolin-2-yl)-N-methylbenzamide (UM0152893) displayed sub-micromolar enzyme inhibition of sEH.
title Generative Active Learning for the Search of Small-molecule Protein Binders
topic Biomolecules
Artificial Intelligence
Machine Learning
url https://arxiv.org/abs/2405.01616